10x Genomics is trading 6.8% down at $73.86 amid broader market pressure, with no fresh company-specific catalyst identified. - The S&P 500, Nasdaq and Dow are lower as investors weigh rising yields, oil and geopolitical concerns, and await Federal Reserve minutes. - The decline follows a sharp October 6 pullback, which reporting attributed mainly to profit-taking after a strong rally tied to recent product-launch enthusiasm, not a new negative company announcement.